Symbols / PFSA $0.83 -5.51%
PFSA Chart
About
Profusa, Inc. develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery. The company researches and develops the Lumee Glucose Platform which is designed to monitor glucose levels in interstitial fluid. Profusa, Inc. is based in Berkeley, California.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Medical Devices | Market Cap | 1.13M |
| Enterprise Value | 18.83M | Income | -29.51M | Sales | — |
| Book/sh | -61.03 | Cash/sh | 3.44 | Dividend Yield | — |
| Payout | 0.00% | Employees | — | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | inf | P/B | -0.01 | P/C | — |
| EV/EBITDA | — | EV/Sales | — | Quick Ratio | 0.13 |
| Current Ratio | 0.18 | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | -53.03 | EPS next Y | — | EPS Growth | — |
| Revenue Growth | — | Earnings | — | ROA | -4.65% |
| ROE | — | ROIC | — | Gross Margin | 0.00% |
| Oper. Margin | 0.00% | Profit Margin | 0.00% | Shs Outstand | 1.36M |
| Shs Float | 789.18K | Short Float | 32.20% | Short Ratio | 0.54 |
| Short Interest | — | 52W High | 412.50 | 52W Low | 0.82 |
| Beta | -0.01 | Avg Volume | 627.35K | Volume | 73.93K |
| Target Price | — | Recom | None | Prev Close | $0.88 |
| Price | $0.83 | Change | -5.51% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
$0.83
Latest analyst target
3. DCF / Fair value
$-141.75
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.83
Low
—
High
—
Mean
—
- Biotech Profusa scraps $15M stock sale after revenue outlook shifts - Stock Titan Fri, 27 Feb 2026 08
- Profusa Faces Nasdaq Delisting Risk Amid Bitcoin Exit - TipRanks Fri, 13 Mar 2026 10
- Profusa to shrink share count from 92.4M to 1.2M in reverse split - Stock Titan hu, 05 Feb 2026 08
- PFSA Technical Analysis & Stock Price Forecast - Intellectia AI Sat, 28 Feb 2026 05
- This Penny Stock Is Surging on an Nvidia Boost. Should You Buy Shares Now or Stay Far Away? - Yahoo Finance Fri, 12 Sep 2025 07
- Profusa Stock Spikes As Lumee System Targets Research Market - Benzinga Fri, 16 Jan 2026 08
- Here’s Why Profusa Stock (PFSA) Rocketed Today - TipRanks ue, 30 Dec 2025 08
- Drug trials get new oxygen sensor as Profusa enters $47.9B CRO market - Stock Titan Fri, 16 Jan 2026 08
- Digital health firm revamps debt terms to reduce share dilution - Stock Titan ue, 30 Dec 2025 08
- Surgeons order Profusa oxygen monitors ahead of EU device sign-off - Stock Titan hu, 19 Feb 2026 08
- New French deal brings oxygen monitoring tech to critical limb patients - Stock Titan Wed, 31 Dec 2025 08
- Profusa (Nasdaq: PFSA) U.S. Lumee PAD study hits endpoints, backs potential FDA filing - Stock Titan Mon, 15 Dec 2025 08
- Profusa (Nasdaq: PFSA) to share US pilot PAD Lumee data at LINC 2026 in Leipzig - Stock Titan hu, 11 Dec 2025 08
- PFSA Stock Price, News & Analysis - Stock Titan Fri, 11 Jul 2025 20
- Profusa (NASDAQ: PFSA) to supply distributors in early 2026 as capacity exceeds needs by 2x - Stock Titan ue, 28 Oct 2025 07
Insider Transactions
No recent insider transactions.
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 0.00 | 0.00 | 0.00 |
| TaxRateForCalcs | 0.00 | 0.00 | 0.00 | 0.00 |
| NormalizedEBITDA | -4.81M | -6.00M | -8.72M | -10.24M |
| TotalUnusualItems | -4.50M | 5.19M | ||
| TotalUnusualItemsExcludingGoodwill | -4.50M | 5.19M | ||
| NetIncomeFromContinuingOperationNetMinorityInterest | -9.23M | -10.28M | -20.22M | -10.31M |
| ReconciledDepreciation | 724.00K | 1.18M | ||
| EBITDA | -4.81M | -6.00M | -13.22M | -5.05M |
| EBIT | -4.81M | -6.00M | -13.95M | -6.23M |
| NetInterestIncome | -4.42M | -4.28M | -6.27M | -4.08M |
| InterestExpense | 4.42M | 4.28M | 6.27M | 4.08M |
| NormalizedIncome | -9.23M | -10.28M | -15.72M | -15.50M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -9.23M | -10.28M | -20.22M | -10.31M |
| TotalExpenses | 4.50M | 6.07M | 9.44M | 11.69M |
| TotalOperatingIncomeAsReported | -4.50M | -6.07M | -11.14M | -11.69M |
| DilutedAverageShares | 437.19K | 437.19K | 437.19K | 437.19K |
| BasicAverageShares | 437.19K | 437.19K | 437.19K | 437.19K |
| DilutedEPS | -21.11 | -23.52 | -46.24 | -23.58 |
| BasicEPS | -21.11 | -23.52 | -46.24 | -23.58 |
| DilutedNIAvailtoComStockholders | -9.23M | -10.28M | -20.22M | -10.31M |
| NetIncomeCommonStockholders | -9.23M | -10.28M | -20.22M | -10.31M |
| NetIncome | -9.23M | -10.28M | -20.22M | -10.31M |
| NetIncomeIncludingNoncontrollingInterests | -9.23M | -10.28M | -20.22M | -10.31M |
| NetIncomeContinuousOperations | -9.23M | -10.28M | -20.22M | -10.31M |
| PretaxIncome | -9.23M | -10.28M | -20.22M | -10.31M |
| OtherIncomeExpense | -306.00K | 72.00K | -4.50M | 5.46M |
| OtherNonOperatingIncomeExpenses | -306.00K | 72.00K | -3.00K | 269.00K |
| SpecialIncomeCharges | -6.53M | 105.00K | ||
| OtherSpecialCharges | 6.53M | -105.00K | ||
| GainOnSaleOfSecurity | 2.03M | 5.08M | ||
| NetNonOperatingInterestIncomeExpense | -4.42M | -4.28M | -6.27M | -4.08M |
| InterestExpenseNonOperating | 4.42M | 4.28M | 6.27M | 4.08M |
| OperatingIncome | -4.50M | -6.07M | -9.44M | -11.69M |
| OperatingExpense | 4.50M | 6.07M | 9.44M | 11.69M |
| OtherOperatingExpenses | -100.00K | -45.00K | -742.00K | |
| ResearchAndDevelopment | 1.61M | 2.04M | 4.20M | 7.66M |
| SellingGeneralAndAdministration | 2.99M | 4.08M | 5.24M | 4.77M |
| GeneralAndAdministrativeExpense | 2.99M | 4.08M | 5.24M | 4.77M |
| OtherGandA | 2.99M | 4.08M | 5.24M | 4.77M |
| TotalRevenue | 0.00 | 0.00 | 0.00 | 0.00 |
| OperatingRevenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| OrdinarySharesNumber | 437.19K | 437.19K | 437.19K | 437.19K |
| ShareIssued | 437.19K | 437.19K | 437.19K | 437.19K |
| NetDebt | 48.02M | 40.25M | 30.95M | 15.35M |
| TotalDebt | 48.21M | 40.40M | 31.03M | 24.02M |
| TangibleBookValue | -119.20M | -110.00M | -99.77M | -83.66M |
| InvestedCapital | -71.00M | -69.60M | -68.74M | -67.45M |
| WorkingCapital | -56.87M | -46.41M | -35.49M | -20.65M |
| NetTangibleAssets | -119.20M | -110.00M | -99.77M | -83.66M |
| CapitalLeaseObligations | 0.00 | 7.82M | ||
| CommonStockEquity | -119.20M | -110.00M | -99.77M | -83.66M |
| TotalCapitalization | -119.20M | -110.00M | -99.77M | -82.47M |
| TotalEquityGrossMinorityInterest | -119.20M | -110.00M | -99.77M | -83.66M |
| StockholdersEquity | -119.20M | -110.00M | -99.77M | -83.66M |
| RetainedEarnings | -124.96M | -115.73M | -105.45M | -85.23M |
| AdditionalPaidInCapital | 5.75M | 5.73M | 5.68M | 1.57M |
| CapitalStock | 0.00 | 0.00 | 0.00 | 0.00 |
| CommonStock | 0.00 | 0.00 | 0.00 | 0.00 |
| TotalLiabilitiesNetMinorityInterest | 122.28M | 111.89M | 100.80M | 95.02M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 65.15M | 65.15M | 65.15M | 73.41M |
| PreferredSecuritiesOutsideStockEquity | 65.15M | 65.15M | 65.15M | 65.15M |
| LongTermDebtAndCapitalLeaseObligation | 0.00 | 8.26M | ||
| LongTermCapitalLeaseObligation | 0.00 | 7.07M | ||
| LongTermDebt | 1.19M | |||
| CurrentLiabilities | 57.13M | 46.74M | 35.65M | 21.61M |
| OtherCurrentLiabilities | 2.04M | |||
| CurrentDebtAndCapitalLeaseObligation | 48.21M | 40.40M | 31.03M | 15.76M |
| CurrentCapitalLeaseObligation | 0.00 | 748.00K | ||
| CurrentDebt | 48.21M | 40.40M | 31.03M | 15.01M |
| OtherCurrentBorrowings | 47.30M | 39.55M | 30.46M | 14.63M |
| CurrentNotesPayable | 910.00K | 849.00K | 576.00K | 381.00K |
| PensionandOtherPostRetirementBenefitPlansCurrent | 3.47M | 1.96M | 584.00K | 381.00K |
| PayablesAndAccruedExpenses | 5.45M | 4.38M | 4.04M | 3.44M |
| CurrentAccruedExpenses | 496.00K | 391.00K | 609.00K | 178.00K |
| Payables | 4.95M | 3.99M | 3.43M | 3.26M |
| AccountsPayable | 4.95M | 3.99M | 3.43M | 3.26M |
| TotalAssets | 3.07M | 1.89M | 1.03M | 11.36M |
| TotalNonCurrentAssets | 2.81M | 1.56M | 871.00K | 10.40M |
| OtherNonCurrentAssets | 56.00K | 31.00K | 30.00K | 293.00K |
| NonCurrentDeferredAssets | 2.76M | 1.53M | 841.00K | 0.00 |
| NetPPE | 0.00 | 2.00K | 0.00 | 10.11M |
| AccumulatedDepreciation | -821.00K | -778.00K | ||
| GrossPPE | 0.00 | 2.00K | 821.00K | 10.89M |
| Leases | 0.00 | 77.00K | ||
| OtherProperties | 2.00K | 41.00K | 10.03M | |
| MachineryFurnitureEquipment | 780.00K | 780.00K | ||
| Properties | 0.00 | 0.00 | ||
| CurrentAssets | 260.00K | 333.00K | 160.00K | 958.00K |
| OtherCurrentAssets | 82.00K | 64.00K | ||
| PrepaidAssets | 69.00K | 146.00K | ||
| Receivables | 0.00 | 45.00K | 0.00 | 38.00K |
| OtherReceivables | 45.00K | |||
| AccountsReceivable | 0.00 | 38.00K | ||
| CashCashEquivalentsAndShortTermInvestments | 191.00K | 142.00K | 78.00K | 856.00K |
| CashAndCashEquivalents | 191.00K | 142.00K | 78.00K | 856.00K |
| CashFinancial | 191.00K | 142.00K | 78.00K | 856.00K |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -2.07M | -4.40M | -7.70M | -10.69M |
| RepaymentOfDebt | -150.00K | -151.00K | -358.00K | 0.00 |
| IssuanceOfDebt | 3.23M | 5.21M | 8.05M | 8.70M |
| CapitalExpenditure | -2.00K | |||
| EndCashPosition | 191.00K | 142.00K | 78.00K | 856.00K |
| BeginningCashPosition | 142.00K | 78.00K | 856.00K | 2.80M |
| ChangesInCash | 49.00K | 64.00K | -778.00K | -1.94M |
| FinancingCashFlow | 2.12M | 4.47M | 6.92M | 8.75M |
| CashFlowFromContinuingFinancingActivities | 2.12M | 4.47M | 6.92M | 8.75M |
| NetOtherFinancingCharges | -961.00K | -614.00K | -789.00K | |
| ProceedsFromStockOptionExercised | 0.00 | 23.00K | 17.00K | 51.00K |
| NetIssuancePaymentsOfDebt | 3.08M | 5.06M | 7.70M | 8.70M |
| NetShortTermDebtIssuance | 3.08M | 5.06M | 7.70M | 7.39M |
| ShortTermDebtPayments | -150.00K | -151.00K | -358.00K | 0.00 |
| ShortTermDebtIssuance | 3.23M | 5.21M | 8.05M | 7.39M |
| NetLongTermDebtIssuance | 0.00 | 1.30M | ||
| LongTermDebtIssuance | 0.00 | 1.30M | ||
| InvestingCashFlow | 0.00 | -2.00K | ||
| CashFlowFromContinuingInvestingActivities | 0.00 | -2.00K | ||
| NetPPEPurchaseAndSale | 0.00 | -2.00K | ||
| PurchaseOfPPE | 0.00 | -2.00K | ||
| OperatingCashFlow | -2.07M | -4.40M | -7.70M | -10.69M |
| CashFlowFromContinuingOperatingActivities | -2.07M | -4.40M | -7.70M | -10.69M |
| ChangeInWorkingCapital | 2.41M | 1.54M | 909.00K | -522.00K |
| ChangeInOtherCurrentLiabilities | -426.00K | -672.00K | ||
| ChangeInOtherCurrentAssets | -25.00K | -1.00K | -25.00K | -4.00K |
| ChangeInPayablesAndAccruedExpense | 2.31M | 1.65M | 1.34M | -287.00K |
| ChangeInAccruedExpense | 1.66M | 1.12M | 634.00K | -227.00K |
| ChangeInPayable | 645.00K | 533.00K | 706.00K | -60.00K |
| ChangeInAccountPayable | 645.00K | 533.00K | 706.00K | -60.00K |
| ChangeInPrepaidAssets | 77.00K | -64.00K | -18.00K | 70.00K |
| ChangeInReceivables | 45.00K | -45.00K | 38.00K | 371.00K |
| OtherNonCashItems | 4.74M | 4.30M | 3.99M | 4.08M |
| StockBasedCompensation | 21.00K | 33.00K | 111.00K | 72.00K |
| DepreciationAmortizationDepletion | 724.00K | 1.18M | ||
| DepreciationAndAmortization | 724.00K | 1.18M | ||
| Depreciation | 724.00K | 1.18M | ||
| OperatingGainsLosses | 2.00K | 6.78M | -5.19M | |
| GainLossOnInvestmentSecurities | -2.03M | -5.08M | ||
| GainLossOnSaleOfPPE | 2.00K | 0.00 | ||
| NetIncomeFromContinuingOperations | -9.23M | -10.28M | -20.22M | -10.31M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for PFSA
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|